As shown in Figure 1b, treatment with orlistat, SMF, SAF, or SMF + SAF for 3 weeks after induction of obesity significantly downregulated the mRNA levels of the FTO gene in all treatment groups in a dose-dependent manner when compared with the untreated control (group 2). The gene discussed is FTO; the disease is obesity disorder.